Strides oral cancer drug plant gets European nod

04 Jul 2011 Evaluate

Strides Arcolab Ltd’s tablets and capsules facility in its oncology medicine complex had received European regulatory approval. It expected to take two products to Europe during the July-September third quarter this year. The oral dosages facility is part of Onco Therapies Ltd, the cancer drugs arm under Strides subsidiary, Agila Specialities. OTL's injectables facility is already approved by major regulatory agencies, enabling Strides to sell its products in many overseas markets. In Europe, it has made 18 filings for oncology products that have potential local sales of $3.2 billion.crackcrack

Strides Pharma Scien Share Price

652.55 -10.65 (-1.61%)
29-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.80
Dr. Reddys Lab 1176.25
Cipla 1541.00
Lupin 2067.40
Zydus Lifesciences 887.95
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...